MILANO–(BUSINESS WIRE)–Dopo la chiusura di un round di finanziamento di serie B da parte di AAVantgarde, AGC Biologics ha annunciato un nuovo accordo di produzione con l’azienda biotech, che rappresenta il progresso più recente di AGC Biologics nel m…
Newer players update the basics in dry eye treatment
Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to get the job done. It makes me chuckle when I see modern medications that have little or nothing to do with tear volume evaluate…
Newer players update the basics in dry eye treatment
Once upon a time, dry eye disease was simple.Like a desert, an eye with dry eye disease (DED) simply had too little water to get the job done. It makes me chuckle when I see modern medications that have little or nothing to do with tear volume evaluate…
‘A historic moment’: Medical societies unite at Lifestyle Medicine Conference
DALLAS — Leaders of several medical organizations came together at the American College of Lifestyle of Medicine’s annual conference to highlight the importance of integrating lifestyle medicine across all of health care.Padmaja Patel, MD, DipABLM, FAC…
AGC Biologics to Manufacture AAVantgarde’s Dual-Vector Gene Therapies for Inherited Retinal Disorders
MILAN–(BUSINESS WIRE)– #Biotech–On the heels of AAVantgarde closing a Series B financing round, AGC Biologics announced a new manufacturing agreement with the biotechnology company, marking AGC Biologics’ latest advancement in the adeno-associated v…
Practices need to prepare for new technology
Click here to read the Cover Story, “Digital future of ophthalmology is now.”As ophthalmology practices continue to embrace digital transformation, one of the greatest challenges is not the technology itself — it is managing expectations.That might sou…